+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Immunodiagnostics Market 2023-2027

  • PDF Icon

    Report

  • 169 Pages
  • April 2023
  • Region: Global
  • TechNavio
  • ID: 5143040
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The immunodiagnostics market is forecasted to grow by USD 22669.75 mn during 2022-2027, accelerating at a CAGR of 12% during the forecast period. The report on the immunodiagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased demand for biomarker-based tests, advancements in technology in immunodiagnostics, and the rising geriatric population.

The immunodiagnostics market is segmented as below:

By Product

  • Reagents and consumables
  • Immunodiagnostic systems

By Application

  • Oncology and endocrinology
  • Hepatitis and retrovirus
  • Infectious disease
  • GI stool
  • Other applications

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growth in demand for personalized medicine as one of the prime reasons driving the immunodiagnostics market growth during the next few years. Also, the emergence of point-of-care testing (POCT) and rising demand for automated systems will lead to sizable demand in the market.

The report on the immunodiagnostics market covers the following areas:

  • Immunodiagnostics market sizing
  • Immunodiagnostics market forecast
  • Immunodiagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunodiagnostics market vendors that include Abbott Laboratories, Adaptive Biotechnologies Corp., AESKU.GROUP GmbH and Co. KG, bioMerieux SA, Danaher Corp., Exagen Inc., F. Hoffmann La Roche Ltd., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, Nexus Dx Inc., Omega Diagnostics Group Plc, QuidelOrtho Corp., Seramun Diagnostica GmbH, Siemens AG, SQI Diagnostics Inc., Sysmex Corp., Thermo Fisher Scientific Inc., Werfenlife SA, Tecan Trading AG, OraSure Technologies Inc., and DiaSorin SpA. Also, the immunodiagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global immunodiagnostics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global immunodiagnostics market 2017 - 2021 ($ million)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Reagents and consumables - Market size and forecast 2022-2027
Exhibit 34: Chart on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Reagents and consumables - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Reagents and consumables - Year-over-year growth 2022-2027 (%)
6.4 Immunodiagnostic systems - Market size and forecast 2022-2027
Exhibit 38: Chart on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Application
7.1 Market segments
Exhibit 44: Chart on Application - Market share 2022-2027 (%)
Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 46: Chart on Comparison by Application
Exhibit 47: Data Table on Comparison by Application
7.3 Oncology and endocrinology - Market size and forecast 2022-2027
Exhibit 48: Chart on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
7.4 Hepatitis and retrovirus - Market size and forecast 2022-2027
Exhibit 52: Chart on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
7.5 Infectious disease - Market size and forecast 2022-2027
Exhibit 56: Chart on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Infectious disease - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Infectious disease - Year-over-year growth 2022-2027 (%)
7.6 GI stool - Market size and forecast 2022-2027
Exhibit 60: Chart on GI stool - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on GI stool - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on GI stool - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on GI stool - Year-over-year growth 2022-2027 (%)
7.7 Other applications - Market size and forecast 2022-2027
Exhibit 64: Chart on Other applications - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Other applications - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Other applications - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Other applications - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Application
Exhibit 68: Market opportunity by Application ($ million)
Exhibit 69: Data Table on Market opportunity by Application ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 119: Abbott Laboratories - Overview
Exhibit 120: Abbott Laboratories - Business segments
Exhibit 121: Abbott Laboratories - Key news
Exhibit 122: Abbott Laboratories - Key offerings
Exhibit 123: Abbott Laboratories - Segment focus
12.4 Adaptive Biotechnologies Corp.
Exhibit 124: Adaptive Biotechnologies Corp. - Overview
Exhibit 125: Adaptive Biotechnologies Corp. - Product / Service
Exhibit 126: Adaptive Biotechnologies Corp. - Key offerings
12.5 AESKU.GROUP GmbH and Co. KG
Exhibit 127: AESKU.GROUP GmbH and Co. KG - Overview
Exhibit 128: AESKU.GROUP GmbH and Co. KG - Product / Service
Exhibit 129: AESKU.GROUP GmbH and Co. KG - Key offerings
12.6 bioMerieux SA
Exhibit 130: bioMerieux SA - Overview
Exhibit 131: bioMerieux SA - Product / Service
Exhibit 132: bioMerieux SA - Key offerings
12.7 Danaher Corp.
Exhibit 133: Danaher Corp. - Overview
Exhibit 134: Danaher Corp. - Business segments
Exhibit 135: Danaher Corp. - Key news
Exhibit 136: Danaher Corp. - Key offerings
Exhibit 137: Danaher Corp. - Segment focus
12.8 DiaSorin SpA
Exhibit 138: DiaSorin SpA - Overview
Exhibit 139: DiaSorin SpA - Business segments
Exhibit 140: DiaSorin SpA - Key news
Exhibit 141: DiaSorin SpA - Key offerings
Exhibit 142: DiaSorin SpA - Segment focus
12.9 F. Hoffmann La Roche Ltd.
Exhibit 143: F. Hoffmann La Roche Ltd. - Overview
Exhibit 144: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 145: F. Hoffmann La Roche Ltd. - Key news
Exhibit 146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 147: F. Hoffmann La Roche Ltd. - Segment focus
12.10 HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
Exhibit 148: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview
Exhibit 149: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product / Service
Exhibit 150: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings
12.11 OraSure Technologies Inc.
Exhibit 151: OraSure Technologies Inc. - Overview
Exhibit 152: OraSure Technologies Inc. - Business segments
Exhibit 153: OraSure Technologies Inc. - Key offerings
Exhibit 154: OraSure Technologies Inc. - Segment focus
12.12 QuidelOrtho Corp.
Exhibit 155: QuidelOrtho Corp. - Overview
Exhibit 156: QuidelOrtho Corp. - Product / Service
Exhibit 157: QuidelOrtho Corp. - Key offerings
12.13 Siemens AG
Exhibit 158: Siemens AG - Overview
Exhibit 159: Siemens AG - Business segments
Exhibit 160: Siemens AG - Key news
Exhibit 161: Siemens AG - Key offerings
Exhibit 162: Siemens AG - Segment focus
12.14 SQI Diagnostics Inc.
Exhibit 163: SQI Diagnostics Inc. - Overview
Exhibit 164: SQI Diagnostics Inc. - Product / Service
Exhibit 165: SQI Diagnostics Inc. - Key offerings
12.15 Sysmex Corp.
Exhibit 166: Sysmex Corp. - Overview
Exhibit 167: Sysmex Corp. - Business segments
Exhibit 168: Sysmex Corp. - Key offerings
Exhibit 169: Sysmex Corp. - Segment focus
12.16 Tecan Trading AG
Exhibit 170: Tecan Trading AG - Overview
Exhibit 171: Tecan Trading AG - Business segments
Exhibit 172: Tecan Trading AG - Key offerings
Exhibit 173: Tecan Trading AG - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 174: Thermo Fisher Scientific Inc. - Overview
Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
Exhibit 176: Thermo Fisher Scientific Inc. - Key news
Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 179: Inclusions checklist
Exhibit 180: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 181: Currency conversion rates for US$
13.4 Research methodology
Exhibit 182: Research methodology
Exhibit 183: Validation techniques employed for market sizing
Exhibit 184: Information sources
13.5 List of abbreviations
Exhibit 185: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global immunodiagnostics market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Product - Market share 2022-2027 (%)
Exhibits 31: Data Table on Product - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Reagents and consumables - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Reagents and consumables - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Product ($ million)
Exhibits 43: Data Table on Market opportunity by Product ($ million)
Exhibits 44: Chart on Application - Market share 2022-2027 (%)
Exhibits 45: Data Table on Application - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by Application
Exhibits 47: Data Table on Comparison by Application
Exhibits 48: Chart on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Data Table on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Chart on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Infectious disease - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Infectious disease - Year-over-year growth 2022-2027 (%)
Exhibits 60: Chart on GI stool - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Data Table on GI stool - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Chart on GI stool - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on GI stool - Year-over-year growth 2022-2027 (%)
Exhibits 64: Chart on Other applications - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Data Table on Other applications - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Chart on Other applications - Year-over-year growth 2022-2027 (%)
Exhibits 67: Data Table on Other applications - Year-over-year growth 2022-2027 (%)
Exhibits 68: Market opportunity by Application ($ million)
Exhibits 69: Data Table on Market opportunity by Application ($ million)
Exhibits 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 73: Chart on Geographic comparison
Exhibits 74: Data Table on Geographic comparison
Exhibits 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 107: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 110: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 111: Market opportunity By Geographical Landscape ($ million)
Exhibits 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 113: Impact of drivers and challenges in 2022 and 2027
Exhibits 114: Overview on Criticality of inputs and Factors of differentiation
Exhibits 115: Overview on factors of disruption
Exhibits 116: Impact of key risks on business
Exhibits 117: Vendors covered
Exhibits 118: Matrix on vendor position and classification
Exhibits 119: Abbott Laboratories - Overview
Exhibits 120: Abbott Laboratories - Business segments
Exhibits 121: Abbott Laboratories - Key news
Exhibits 122: Abbott Laboratories - Key offerings
Exhibits 123: Abbott Laboratories - Segment focus
Exhibits 124: Adaptive Biotechnologies Corp. - Overview
Exhibits 125: Adaptive Biotechnologies Corp. - Product / Service
Exhibits 126: Adaptive Biotechnologies Corp. - Key offerings
Exhibits 127: AESKU.GROUP GmbH and Co. KG - Overview
Exhibits 128: AESKU.GROUP GmbH and Co. KG - Product / Service
Exhibits 129: AESKU.GROUP GmbH and Co. KG - Key offerings
Exhibits 130: bioMerieux SA - Overview
Exhibits 131: bioMerieux SA - Product / Service
Exhibits 132: bioMerieux SA - Key offerings
Exhibits 133: Danaher Corp. - Overview
Exhibits 134: Danaher Corp. - Business segments
Exhibits 135: Danaher Corp. - Key news
Exhibits 136: Danaher Corp. - Key offerings
Exhibits 137: Danaher Corp. - Segment focus
Exhibits 138: DiaSorin SpA - Overview
Exhibits 139: DiaSorin SpA - Business segments
Exhibits 140: DiaSorin SpA - Key news
Exhibits 141: DiaSorin SpA - Key offerings
Exhibits 142: DiaSorin SpA - Segment focus
Exhibits 143: F. Hoffmann La Roche Ltd. - Overview
Exhibits 144: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 145: F. Hoffmann La Roche Ltd. - Key news
Exhibits 146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 147: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 148: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview
Exhibits 149: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product / Service
Exhibits 150: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings
Exhibits 151: OraSure Technologies Inc. - Overview
Exhibits 152: OraSure Technologies Inc. - Business segments
Exhibits 153: OraSure Technologies Inc. - Key offerings
Exhibits 154: OraSure Technologies Inc. - Segment focus
Exhibits 155: QuidelOrtho Corp. - Overview
Exhibits 156: QuidelOrtho Corp. - Product / Service
Exhibits 157: QuidelOrtho Corp. - Key offerings
Exhibits 158: Siemens AG - Overview
Exhibits 159: Siemens AG - Business segments
Exhibits 160: Siemens AG - Key news
Exhibits 161: Siemens AG - Key offerings
Exhibits 162: Siemens AG - Segment focus
Exhibits 163: SQI Diagnostics Inc. - Overview
Exhibits 164: SQI Diagnostics Inc. - Product / Service
Exhibits 165: SQI Diagnostics Inc. - Key offerings
Exhibits 166: Sysmex Corp. - Overview
Exhibits 167: Sysmex Corp. - Business segments
Exhibits 168: Sysmex Corp. - Key offerings
Exhibits 169: Sysmex Corp. - Segment focus
Exhibits 170: Tecan Trading AG - Overview
Exhibits 171: Tecan Trading AG - Business segments
Exhibits 172: Tecan Trading AG - Key offerings
Exhibits 173: Tecan Trading AG - Segment focus
Exhibits 174: Thermo Fisher Scientific Inc. - Overview
Exhibits 175: Thermo Fisher Scientific Inc. - Business segments
Exhibits 176: Thermo Fisher Scientific Inc. - Key news
Exhibits 177: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 178: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 179: Inclusions checklist
Exhibits 180: Exclusions checklist
Exhibits 181: Currency conversion rates for US$
Exhibits 182: Research methodology
Exhibits 183: Validation techniques employed for market sizing
Exhibits 184: Information sources
Exhibits 185: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global immunodiagnostics market: Abbott Laboratories, bioMerieux SA, Danaher Corp., F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., Quest Diagnostics Inc., Siemens AG, Sysmex Corp., Tecan Group Ltd., and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is product launches.`

According to the report, one of the major drivers for this market is technological advances.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Adaptive Biotechnologies Corp.
  • AESKU.GROUP GmbH and Co. KG
  • bioMerieux SA
  • Danaher Corp.
  • Exagen Inc.
  • F. Hoffmann La Roche Ltd.
  • HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
  • Nexus Dx Inc.
  • Omega Diagnostics Group Plc
  • QuidelOrtho Corp.
  • Seramun Diagnostica GmbH
  • Siemens AG
  • SQI Diagnostics Inc.
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.
  • Werfenlife SA
  • Tecan Trading AG
  • OraSure Technologies Inc.
  • DiaSorin SpA